Global Mirtazapine Market Research Report 2023

Mirtazapine Market

Mirtazapine ACTS on central presynaptic receptor 2 antagonist and enhances adrenergic nerve conduction.It regulates the function of 5-ht by interacting with central serotonin (5-ht2, 5-ht3) receptors.Both of mirtazapine's optically active enantiomers have antidepressant activity, with the levorotatory block of type 2 receptor and 5-ht2 receptor, and the right-handed block of 5-ht3 receptor.Mirtazapine has sedative effects, is well tolerated, has almost no anticholinergic effects, and its therapeutic dose has no effect on the cardiovascular system.

The global Mirtazapine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Mirtazapine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Mirtazapine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Mirtazapine include Novartis, Organon, CIMA Labs.Inc., Merck & Co, Teva, Mylan, Sun Pharmaceutical, IMPAX and Aurobindo Pharma, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mirtazapine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mirtazapine.

The Mirtazapine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Mirtazapine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Mirtazapine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Scope of Mirtazapine Market Report

Core Chapters

1.1 Product Overview and Scope of Mirtazapine

1.2 Mirtazapine Segment by Type

1.2.1 Global Mirtazapine Market Value Comparison by Type (2023-2029)

1.2.2 15 Mg Tablets

1.2.3 30 Mg Tablets

1.2.4 45 Mg Tablets

1.3 Mirtazapine Segment by Application

1.3.1 Global Mirtazapine Market Value by Application: (2023-2029)

1.3.2 Depression

1.3.3 Insomnia

1.3.4 Weight Loss

1.3.5 Mood Swings

1.3.6 Other

1.4 Global Mirtazapine Market Size Estimates and Forecasts

1.4.1 Global Mirtazapine Revenue 2018-2029

1.4.2 Global Mirtazapine Sales 2018-2029

1.4.3 Global Mirtazapine Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Mirtazapine Sales Market Share by Manufacturers (2018-2023)

2.2 Global Mirtazapine Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Mirtazapine Average Price by Manufacturers (2018-2023)

2.4 Global Mirtazapine Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Mirtazapine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Mirtazapine, Product Type & Application

2.7 Mirtazapine Market Competitive Situation and Trends

2.7.1 Mirtazapine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Mirtazapine Players Market Share by Revenue

2.7.3 Global Mirtazapine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Mirtazapine Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Mirtazapine Global Mirtazapine Sales by Region: 2018-2029

3.2.1 Global Mirtazapine Sales by Region: 2018-2023

3.2.2 Global Mirtazapine Sales by Region: 2024-2029

3.3 Global Mirtazapine Global Mirtazapine Revenue by Region: 2018-2029

3.3.1 Global Mirtazapine Revenue by Region: 2018-2023

3.3.2 Global Mirtazapine Revenue by Region: 2024-2029

3.4 North America Mirtazapine Market Facts & Figures by Country

3.4.1 North America Mirtazapine Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Mirtazapine Sales by Country (2018-2029)

3.4.3 North America Mirtazapine Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Mirtazapine Market Facts & Figures by Country

3.5.1 Europe Mirtazapine Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Mirtazapine Sales by Country (2018-2029)

3.5.3 Europe Mirtazapine Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Mirtazapine Market Facts & Figures by Country

3.6.1 Asia Pacific Mirtazapine Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Mirtazapine Sales by Country (2018-2029)

3.6.3 Asia Pacific Mirtazapine Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Mirtazapine Market Facts & Figures by Country

3.7.1 Latin America Mirtazapine Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Mirtazapine Sales by Country (2018-2029)

3.7.3 Latin America Mirtazapine Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Mirtazapine Market Facts & Figures by Country

3.8.1 Middle East and Africa Mirtazapine Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Mirtazapine Sales by Country (2018-2029)

3.8.3 Middle East and Africa Mirtazapine Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Mirtazapine Sales by Type (2018-2029)

4.1.1 Global Mirtazapine Sales by Type (2018-2023)

4.1.2 Global Mirtazapine Sales by Type (2024-2029)

4.1.3 Global Mirtazapine Sales Market Share by Type (2018-2029)

4.2 Global Mirtazapine Revenue by Type (2018-2029)

4.2.1 Global Mirtazapine Revenue by Type (2018-2023)

4.2.2 Global Mirtazapine Revenue by Type (2024-2029)

4.2.3 Global Mirtazapine Revenue Market Share by Type (2018-2029)

4.3 Global Mirtazapine Price by Type (2018-2029)

5.1 Global Mirtazapine Sales by Application (2018-2029)

5.1.1 Global Mirtazapine Sales by Application (2018-2023)

5.1.2 Global Mirtazapine Sales by Application (2024-2029)

5.1.3 Global Mirtazapine Sales Market Share by Application (2018-2029)

5.2 Global Mirtazapine Revenue by Application (2018-2029)

5.2.1 Global Mirtazapine Revenue by Application (2018-2023)

5.2.2 Global Mirtazapine Revenue by Application (2024-2029)

5.2.3 Global Mirtazapine Revenue Market Share by Application (2018-2029)

5.3 Global Mirtazapine Price by Application (2018-2029)

6.1 Novartis

6.1.1 Novartis Corporation Information

6.1.2 Novartis Description and Business Overview

6.1.3 Novartis Mirtazapine Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Novartis Mirtazapine Product Portfolio

6.1.5 Novartis Recent Developments/Updates

6.2 Organon

6.2.1 Organon Corporation Information

6.2.2 Organon Description and Business Overview

6.2.3 Organon Mirtazapine Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Organon Mirtazapine Product Portfolio

6.2.5 Organon Recent Developments/Updates

6.3 CIMA Labs.Inc.

6.3.1 CIMA Labs.Inc. Corporation Information

6.3.2 CIMA Labs.Inc. Description and Business Overview

6.3.3 CIMA Labs.Inc. Mirtazapine Sales, Revenue and Gross Margin (2018-2023)

6.3.4 CIMA Labs.Inc. Mirtazapine Product Portfolio

6.3.5 CIMA Labs.Inc. Recent Developments/Updates

6.4 Merck & Co

6.4.1 Merck & Co Corporation Information

6.4.2 Merck & Co Description and Business Overview

6.4.3 Merck & Co Mirtazapine Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Merck & Co Mirtazapine Product Portfolio

6.4.5 Merck & Co Recent Developments/Updates

6.5 Teva

6.5.1 Teva Corporation Information

6.5.2 Teva Description and Business Overview

6.5.3 Teva Mirtazapine Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Teva Mirtazapine Product Portfolio

6.5.5 Teva Recent Developments/Updates

6.6 Mylan

6.6.1 Mylan Corporation Information

6.6.2 Mylan Description and Business Overview

6.6.3 Mylan Mirtazapine Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Mylan Mirtazapine Product Portfolio

6.6.5 Mylan Recent Developments/Updates

6.7 Sun Pharmaceutical

6.6.1 Sun Pharmaceutical Corporation Information

6.6.2 Sun Pharmaceutical Description and Business Overview

6.6.3 Sun Pharmaceutical Mirtazapine Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Sun Pharmaceutical Mirtazapine Product Portfolio

6.7.5 Sun Pharmaceutical Recent Developments/Updates

6.8 IMPAX

6.8.1 IMPAX Corporation Information

6.8.2 IMPAX Description and Business Overview

6.8.3 IMPAX Mirtazapine Sales, Revenue and Gross Margin (2018-2023)

6.8.4 IMPAX Mirtazapine Product Portfolio

6.8.5 IMPAX Recent Developments/Updates

6.9 Aurobindo Pharma

6.9.1 Aurobindo Pharma Corporation Information

6.9.2 Aurobindo Pharma Description and Business Overview

6.9.3 Aurobindo Pharma Mirtazapine Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Aurobindo Pharma Mirtazapine Product Portfolio

6.9.5 Aurobindo Pharma Recent Developments/Updates

6.10 Zydus Pharmaceuticals

6.10.1 Zydus Pharmaceuticals Corporation Information

6.10.2 Zydus Pharmaceuticals Description and Business Overview

6.10.3 Zydus Pharmaceuticals Mirtazapine Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Zydus Pharmaceuticals Mirtazapine Product Portfolio

6.10.5 Zydus Pharmaceuticals Recent Developments/Updates

6.11 APOTEX

6.11.1 APOTEX Corporation Information

6.11.2 APOTEX Mirtazapine Description and Business Overview

6.11.3 APOTEX Mirtazapine Sales, Revenue and Gross Margin (2018-2023)

6.11.4 APOTEX Mirtazapine Product Portfolio

6.11.5 APOTEX Recent Developments/Updates

6.12 Harbin Sanlian Pharmaceutical

6.12.1 Harbin Sanlian Pharmaceutical Corporation Information

6.12.2 Harbin Sanlian Pharmaceutical Mirtazapine Description and Business Overview

6.12.3 Harbin Sanlian Pharmaceutical Mirtazapine Sales, Revenue and Gross Margin (2018-2023)

6.12.4 Harbin Sanlian Pharmaceutical Mirtazapine Product Portfolio

6.12.5 Harbin Sanlian Pharmaceutical Recent Developments/Updates

6.13 Shanxi Kangbao Biological Products

6.13.1 Shanxi Kangbao Biological Products Corporation Information

6.13.2 Shanxi Kangbao Biological Products Mirtazapine Description and Business Overview

6.13.3 Shanxi Kangbao Biological Products Mirtazapine Sales, Revenue and Gross Margin (2018-2023)

6.13.4 Shanxi Kangbao Biological Products Mirtazapine Product Portfolio

6.13.5 Shanxi Kangbao Biological Products Recent Developments/Updates

6.14 Huayu Pharmaceutical

6.14.1 Huayu Pharmaceutical Corporation Information

6.14.2 Huayu Pharmaceutical Mirtazapine Description and Business Overview

6.14.3 Huayu Pharmaceutical Mirtazapine Sales, Revenue and Gross Margin (2018-2023)

6.14.4 Huayu Pharmaceutical Mirtazapine Product Portfolio

6.14.5 Huayu Pharmaceutical Recent Developments/Updates

6.15 Hangzhou Moshadong Pharmaceutical

6.15.1 Hangzhou Moshadong Pharmaceutical Corporation Information

6.15.2 Hangzhou Moshadong Pharmaceutical Mirtazapine Description and Business Overview

6.15.3 Hangzhou Moshadong Pharmaceutical Mirtazapine Sales, Revenue and Gross Margin (2018-2023)

6.15.4 Hangzhou Moshadong Pharmaceutical Mirtazapine Product Portfolio

6.15.5 Hangzhou Moshadong Pharmaceutical Recent Developments/Updates

6.16 Shanghai Xinyi Vientiane Pharmaceutical

6.16.1 Shanghai Xinyi Vientiane Pharmaceutical Corporation Information

6.16.2 Shanghai Xinyi Vientiane Pharmaceutical Mirtazapine Description and Business Overview

6.16.3 Shanghai Xinyi Vientiane Pharmaceutical Mirtazapine Sales, Revenue and Gross Margin (2018-2023)

6.16.4 Shanghai Xinyi Vientiane Pharmaceutical Mirtazapine Product Portfolio

6.16.5 Shanghai Xinyi Vientiane Pharmaceutical Recent Developments/Updates

7.1 Mirtazapine Industry Chain Analysis

7.2 Mirtazapine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Mirtazapine Production Mode & Process

7.4 Mirtazapine Sales and Marketing

7.4.1 Mirtazapine Sales Channels

7.4.2 Mirtazapine Distributors

7.5 Mirtazapine Customers

8.1 Mirtazapine Industry Trends

8.2 Mirtazapine Market Drivers

8.3 Mirtazapine Market Challenges

8.4 Mirtazapine Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Mirtazapine Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Mirtazapine Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Mirtazapine Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Mirtazapine Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Mirtazapine Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Mirtazapine Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Mirtazapine Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Mirtazapine Average Price (US$/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Mirtazapine, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Mirtazapine, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Mirtazapine, Product Type & Application

    Table 12. Global Key Manufacturers of Mirtazapine, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Mirtazapine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mirtazapine as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Mirtazapine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Mirtazapine Sales by Region (2018-2023) & (K Units)

    Table 18. Global Mirtazapine Sales Market Share by Region (2018-2023)

    Table 19. Global Mirtazapine Sales by Region (2024-2029) & (K Units)

    Table 20. Global Mirtazapine Sales Market Share by Region (2024-2029)

    Table 21. Global Mirtazapine Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Mirtazapine Revenue Market Share by Region (2018-2023)

    Table 23. Global Mirtazapine Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Mirtazapine Revenue Market Share by Region (2024-2029)

    Table 25. North America Mirtazapine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Mirtazapine Sales by Country (2018-2023) & (K Units)

    Table 27. North America Mirtazapine Sales by Country (2024-2029) & (K Units)

    Table 28. North America Mirtazapine Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Mirtazapine Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Mirtazapine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Mirtazapine Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Mirtazapine Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Mirtazapine Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Mirtazapine Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Mirtazapine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Mirtazapine Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Mirtazapine Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Mirtazapine Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Mirtazapine Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Mirtazapine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Mirtazapine Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Mirtazapine Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Mirtazapine Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Mirtazapine Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Mirtazapine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Mirtazapine Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Mirtazapine Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Mirtazapine Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Mirtazapine Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Mirtazapine Sales (K Units) by Type (2018-2023)

    Table 51. Global Mirtazapine Sales (K Units) by Type (2024-2029)

    Table 52. Global Mirtazapine Sales Market Share by Type (2018-2023)

    Table 53. Global Mirtazapine Sales Market Share by Type (2024-2029)

    Table 54. Global Mirtazapine Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Mirtazapine Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Mirtazapine Revenue Market Share by Type (2018-2023)

    Table 57. Global Mirtazapine Revenue Market Share by Type (2024-2029)

    Table 58. Global Mirtazapine Price (US$/Unit) by Type (2018-2023)

    Table 59. Global Mirtazapine Price (US$/Unit) by Type (2024-2029)

    Table 60. Global Mirtazapine Sales (K Units) by Application (2018-2023)

    Table 61. Global Mirtazapine Sales (K Units) by Application (2024-2029)

    Table 62. Global Mirtazapine Sales Market Share by Application (2018-2023)

    Table 63. Global Mirtazapine Sales Market Share by Application (2024-2029)

    Table 64. Global Mirtazapine Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Mirtazapine Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Mirtazapine Revenue Market Share by Application (2018-2023)

    Table 67. Global Mirtazapine Revenue Market Share by Application (2024-2029)

    Table 68. Global Mirtazapine Price (US$/Unit) by Application (2018-2023)

    Table 69. Global Mirtazapine Price (US$/Unit) by Application (2024-2029)

    Table 70. Novartis Corporation Information

    Table 71. Novartis Description and Business Overview

    Table 72. Novartis Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 73. Novartis Mirtazapine Product

    Table 74. Novartis Recent Developments/Updates

    Table 75. Organon Corporation Information

    Table 76. Organon Description and Business Overview

    Table 77. Organon Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 78. Organon Mirtazapine Product

    Table 79. Organon Recent Developments/Updates

    Table 80. CIMA Labs.Inc. Corporation Information

    Table 81. CIMA Labs.Inc. Description and Business Overview

    Table 82. CIMA Labs.Inc. Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 83. CIMA Labs.Inc. Mirtazapine Product

    Table 84. CIMA Labs.Inc. Recent Developments/Updates

    Table 85. Merck & Co Corporation Information

    Table 86. Merck & Co Description and Business Overview

    Table 87. Merck & Co Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 88. Merck & Co Mirtazapine Product

    Table 89. Merck & Co Recent Developments/Updates

    Table 90. Teva Corporation Information

    Table 91. Teva Description and Business Overview

    Table 92. Teva Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 93. Teva Mirtazapine Product

    Table 94. Teva Recent Developments/Updates

    Table 95. Mylan Corporation Information

    Table 96. Mylan Description and Business Overview

    Table 97. Mylan Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 98. Mylan Mirtazapine Product

    Table 99. Mylan Recent Developments/Updates

    Table 100. Sun Pharmaceutical Corporation Information

    Table 101. Sun Pharmaceutical Description and Business Overview

    Table 102. Sun Pharmaceutical Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 103. Sun Pharmaceutical Mirtazapine Product

    Table 104. Sun Pharmaceutical Recent Developments/Updates

    Table 105. IMPAX Corporation Information

    Table 106. IMPAX Description and Business Overview

    Table 107. IMPAX Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 108. IMPAX Mirtazapine Product

    Table 109. IMPAX Recent Developments/Updates

    Table 110. Aurobindo Pharma Corporation Information

    Table 111. Aurobindo Pharma Description and Business Overview

    Table 112. Aurobindo Pharma Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 113. Aurobindo Pharma Mirtazapine Product

    Table 114. Aurobindo Pharma Recent Developments/Updates

    Table 115. Zydus Pharmaceuticals Corporation Information

    Table 116. Zydus Pharmaceuticals Description and Business Overview

    Table 117. Zydus Pharmaceuticals Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 118. Zydus Pharmaceuticals Mirtazapine Product

    Table 119. Zydus Pharmaceuticals Recent Developments/Updates

    Table 120. APOTEX Corporation Information

    Table 121. APOTEX Description and Business Overview

    Table 122. APOTEX Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 123. APOTEX Mirtazapine Product

    Table 124. APOTEX Recent Developments/Updates

    Table 125. Harbin Sanlian Pharmaceutical Corporation Information

    Table 126. Harbin Sanlian Pharmaceutical Description and Business Overview

    Table 127. Harbin Sanlian Pharmaceutical Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 128. Harbin Sanlian Pharmaceutical Mirtazapine Product

    Table 129. Harbin Sanlian Pharmaceutical Recent Developments/Updates

    Table 130. Shanxi Kangbao Biological Products Corporation Information

    Table 131. Shanxi Kangbao Biological Products Description and Business Overview

    Table 132. Shanxi Kangbao Biological Products Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 133. Shanxi Kangbao Biological Products Mirtazapine Product

    Table 134. Shanxi Kangbao Biological Products Recent Developments/Updates

    Table 135. Huayu Pharmaceutical Corporation Information

    Table 136. Huayu Pharmaceutical Description and Business Overview

    Table 137. Huayu Pharmaceutical Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 138. Huayu Pharmaceutical Mirtazapine Product

    Table 139. Huayu Pharmaceutical Recent Developments/Updates

    Table 140. Hangzhou Moshadong Pharmaceutical Corporation Information

    Table 141. Hangzhou Moshadong Pharmaceutical Description and Business Overview

    Table 142. Hangzhou Moshadong Pharmaceutical Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 143. Hangzhou Moshadong Pharmaceutical Mirtazapine Product

    Table 144. Hangzhou Moshadong Pharmaceutical Recent Developments/Updates

    Table 145. Shanghai Xinyi Vientiane Pharmaceutical Corporation Information

    Table 146. Shanghai Xinyi Vientiane Pharmaceutical Description and Business Overview

    Table 147. Shanghai Xinyi Vientiane Pharmaceutical Mirtazapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 148. Shanghai Xinyi Vientiane Pharmaceutical Mirtazapine Product

    Table 149. Shanghai Xinyi Vientiane Pharmaceutical Recent Developments/Updates

    Table 150. Key Raw Materials Lists

    Table 151. Raw Materials Key Suppliers Lists

    Table 152. Mirtazapine Distributors List

    Table 153. Mirtazapine Customers List

    Table 154. Mirtazapine Market Trends

    Table 155. Mirtazapine Market Drivers

    Table 156. Mirtazapine Market Challenges

    Table 157. Mirtazapine Market Restraints

    Table 158. Research Programs/Design for This Report

    Table 159. Key Data Information from Secondary Sources

    Table 160. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Mirtazapine

    Figure 2. Global Mirtazapine Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Mirtazapine Market Share by Type in 2022 & 2029

    Figure 4. 15 Mg Tablets Product Picture

    Figure 5. 30 Mg Tablets Product Picture

    Figure 6. 45 Mg Tablets Product Picture

    Figure 7. Global Mirtazapine Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Mirtazapine Market Share by Application in 2022 & 2029

    Figure 9. Depression

    Figure 10. Insomnia

    Figure 11. Weight Loss

    Figure 12. Mood Swings

    Figure 13. Other

    Figure 14. Global Mirtazapine Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Mirtazapine Market Size (2018-2029) & (US$ Million)

    Figure 16. Global Mirtazapine Sales (2018-2029) & (K Units)

    Figure 17. Global Mirtazapine Average Price (US$/Unit) & (2018-2029)

    Figure 18. Mirtazapine Report Years Considered

    Figure 19. Mirtazapine Sales Share by Manufacturers in 2022

    Figure 20. Global Mirtazapine Revenue Share by Manufacturers in 2022

    Figure 21. The Global 5 and 10 Largest Mirtazapine Players: Market Share by Revenue in 2022

    Figure 22. Mirtazapine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 23. Global Mirtazapine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 24. North America Mirtazapine Sales Market Share by Country (2018-2029)

    Figure 25. North America Mirtazapine Revenue Market Share by Country (2018-2029)

    Figure 26. U.S. Mirtazapine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 27. Canada Mirtazapine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. Europe Mirtazapine Sales Market Share by Country (2018-2029)

    Figure 29. Europe Mirtazapine Revenue Market Share by Country (2018-2029)

    Figure 30. Germany Mirtazapine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. France Mirtazapine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. U.K. Mirtazapine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Italy Mirtazapine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. Russia Mirtazapine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. Asia Pacific Mirtazapine Sales Market Share by Region (2018-2029)

    Figure 36. Asia Pacific Mirtazapine Revenue Market Share by Region (2018-2029)

    Figure 37. China Mirtazapine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. Japan Mirtazapine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. South Korea Mirtazapine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. India Mirtazapine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Australia Mirtazapine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Taiwan Mirtazapine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Indonesia Mirtazapine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Thailand Mirtazapine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Malaysia Mirtazapine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Philippines Mirtazapine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Latin America Mirtazapine Sales Market Share by Country (2018-2029)

    Figure 48. Latin America Mirtazapine Revenue Market Share by Country (2018-2029)

    Figure 49. Mexico Mirtazapine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Brazil Mirtazapine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 51. Argentina Mirtazapine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Middle East & Africa Mirtazapine Sales Market Share by Country (2018-2029)

    Figure 53. Middle East & Africa Mirtazapine Revenue Market Share by Country (2018-2029)

    Figure 54. Turkey Mirtazapine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 55. Saudi Arabia Mirtazapine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 56. UAE Mirtazapine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 57. Global Sales Market Share of Mirtazapine by Type (2018-2029)

    Figure 58. Global Revenue Market Share of Mirtazapine by Type (2018-2029)

    Figure 59. Global Mirtazapine Price (US$/Unit) by Type (2018-2029)

    Figure 60. Global Sales Market Share of Mirtazapine by Application (2018-2029)

    Figure 61. Global Revenue Market Share of Mirtazapine by Application (2018-2029)

    Figure 62. Global Mirtazapine Price (US$/Unit) by Application (2018-2029)

    Figure 63. Mirtazapine Value Chain

    Figure 64. Mirtazapine Production Process

    Figure 65. Channels of Distribution (Direct Vs Distribution)

    Figure 66. Distributors Profiles

    Figure 67. Bottom-up and Top-down Approaches for This Report

    Figure 68. Data Triangulation

    Figure 69. Key Executives Interviewed